Use of recombinant human interleukin-2 in conjunction with syngeneic bone marrow transplantation in mice as a model for control of minimal residual disease in malignant hematologic disorders
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
Graft-versus-leukemia reactions after bone marrow transplantation
1990 • 2,781 citations
Spontaneous murine B-cell leukaemia
1978 • 264 citations
The Development of New Immunotherapies for the Treatment of Cancer Using Interleukin-2
1988 • 181 citations
Graft-versus-leukemia reactions after bone marrow transplantation
1990 • 166 citations
Eradication of murine leukemia with histoincompatible marrow grafts in mice conditioned with total lymphoid irradiation (TLI)
1981 • 97 citations
Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors.
1981 • 90 citations
Human Cancer-Associated Antigens: Present Status and Implications for Immunodiagnosis
1985 • 55 citations
Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation.
1983 • 49 citations
Adoptive immunotherapy in conjunction with bone marrow transplantation--amplification of natural host defence mechanisms against cancer by recombinant IL-2.
1988 • 48 citations
Lymphokine-activated killer (LAK) cells. I. Differential recovery of LAK, natural killer cells, and cytotoxic T lymphocytes after a sublethal dose of cyclophosphamide.
1986 • 40 citations
Ultrastructural, cell membrane, and cytogenetic characteristics of B-cell leukemia, a murine model of chronic lymphocytic leukemia.
1981 • 30 citations
BONE MARROW TRANSPLANTATION WITH T-CELL-DEPLETED GRAFTS
1986 • 17 citations